Recombinant Human PPARD Protein，His

PPARD, or Peroxisome Proliferator-Activated Receptor Delta, is a member of the nuclear receptor superfamily that plays a crucial role in regulating various physiological processes, including lipid metabolism, glucose homeostasis, and inflammation. Research on PPARD has gained significant attention due to its potential implications in metabolic disorders, cardiovascular diseases, and cancer. The protein functions as a transcription factor, modulating gene expression in response to fatty acids and other ligands, thereby influencing metabolic pathways. Studies have shown that PPARD activation can enhance fatty acid oxidation, improve insulin sensitivity, and reduce inflammation, making it an attractive therapeutic target for obesity and type 2 diabetes. Additionally, PPARD is implicated in muscle differentiation and endurance exercise adaptations, underscoring its importance in energy metabolism and physical performance. Advances in recombinant protein technology have facilitated the production of PPARD and its variants, enabling detailed structural and functional studies. These studies aim to elucidate the molecular mechanisms by which PPARD exerts its effects and to identify potential pharmacological agents that can selectively modulate its activity. Understanding the biological role of PPARD and its pathways is essential for developing targeted therapies that harness its beneficial effects while minimizing adverse outcomes, thus offering hope for innovative treatments in metabolic and inflammatory diseases.